دورية أكاديمية
أعرض في EDS

Lessons learned from U.S. rapid antiretroviral therapy initiation programs.

التفاصيل البيبلوغرافية
العنوان: Lessons learned from U.S. rapid antiretroviral therapy initiation programs.
المؤلفون: Doshi RK; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.; The HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA), District of Columbia Department of Health, Washington, DC, USA., Hull S; Rutgers University School of Communication and Information, New Brunswick, NJ, USA., Broun A; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA., Boyani S; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA., Moch D; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA., Visconti AJ; The HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA), District of Columbia Department of Health, Washington, DC, USA., Castel AD; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA., Baral S; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA., Colasanti J; Emory University School of Medicine, Atlanta, GA, USA., Rodriguez AE; University of Miami Miller School of Medicine, Miami, FL, USA., Jones J; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Coffey S; University of California San Francisco School of Medicine, San Francisco, CA, USA., Monroe AK; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
المصدر: International journal of STD & AIDS [Int J STD AIDS] 2023 Nov; Vol. 34 (13), pp. 945-955. Date of Electronic Publication: 2023 Jul 17.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052 (Electronic) Linking ISSN: 09564624 NLM ISO Abbreviation: Int J STD AIDS Subsets: MEDLINE
أسماء مطبوعة: Publication: Dec. 2012- : London : Sage
Original Publication: London, U.K. : Royal Society of Medicine Services, c1990-
مواضيع طبية MeSH: HIV Infections*/diagnosis , HIV Infections*/drug therapy, Humans ; Qualitative Research ; Cognition ; Patients ; Communication
مستخلص: Background: Rapid antiretroviral therapy initiation (R-ART) for treatment of HIV has been recommended since 2017, however it has not been adopted widely across the US.
Purpose: The study purpose was to understand facilitators and barriers to R-ART implementation in the U.S.
Research Design: This was a qualitative design involving semi-structured interviews.
Study Sample: The study sample was comprised of the medical leadership of nine US HIV clinics that were early implementers of R-ART.
Data Collection and Analysis: In-depth, semi-structured interviews were performed. The Consolidated Framework for Implementation Research (CFIR) was used to guide thematic analysis.
Results: We identified three main content areas: strong scientific rationale for R-ART, buy-in from multiple key stakeholders, and the condensed timeline of R-ART. The CFIR construct of Evidence Strength and Quality was cited as an important factor in R-ART implementation. Buy-in from key stakeholders and immediate access to medications ensured the success of R-ART implementation. Patient acceptance of the condensed timeline for ART initiation was facilitated when presented in a patient-centered manner, including empathetic communication and addressing other patient needs concurrently. The condensed timeline of R-ART presented logistical challenges and opportunities for the development of intense patient-provider relationships.
Conclusions: Results from the analysis showed that R-ART implementation should address the following: 1) logistical planning to implement HIV treatment with a condensed timeline 2) patients' mixed reactions to a new HIV diagnosis and 3) the high cost of HIV medications.
Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References: J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S206-S216. (PMID: 31764256)
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):44-51. (PMID: 27434707)
Lancet. 2021 Mar 20;397(10279):1127-1138. (PMID: 33617778)
PLoS Med. 2017 Jul 25;14(7):e1002357. (PMID: 28742880)
JAMA. 2020 Oct 27;324(16):1651-1669. (PMID: 33052386)
N Engl J Med. 2013 Jan 17;368(3):207-17. (PMID: 23323897)
AIDS Behav. 2019 Oct;23(Suppl 3):287-295. (PMID: 31520241)
N Engl J Med. 2011 Aug 11;365(6):493-505. (PMID: 21767103)
AIDS Care. 2020 Sep;32(9):1191-1197. (PMID: 31713432)
BMC Infect Dis. 2022 Mar 31;22(1):316. (PMID: 35361148)
N Engl J Med. 2016 Jan 28;374(4):393-4. (PMID: 26816021)
Open Forum Infect Dis. 2018 Jun 28;5(6):ofy104. (PMID: 29992172)
J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686)
Clin Infect Dis. 2021 Jul 1;73(1):e122-e128. (PMID: 32449916)
Antiviral Res. 2014 Mar;103:88-93. (PMID: 24374148)
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S26-31. (PMID: 23673882)
N Engl J Med. 2016 Sep 1;375(9):830-9. (PMID: 27424812)
JAMA. 2019 Mar 5;321(9):844-845. (PMID: 30730529)
PLoS Med. 2016 May 10;13(5):e1002015. (PMID: 27163694)
PLoS One. 2016 Apr 11;11(4):e0152910. (PMID: 27065239)
Curr Opin HIV AIDS. 2015 Jul;10(4):282-9. (PMID: 26049955)
AIDS. 2019 Apr 1;33(5):825-832. (PMID: 30882490)
Implement Sci. 2009 Aug 07;4:50. (PMID: 19664226)
N Engl J Med. 2013 Jan 17;368(3):218-30. (PMID: 23323898)
J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):292-300. (PMID: 30676360)
AIDS Patient Care STDS. 2018 Feb;32(2):39-41. (PMID: 29432044)
J Acquir Immune Defic Syndr. 2022 Jul 1;90(S1):S177-S189. (PMID: 35703770)
معلومات مُعتمدة: P30 AI094189 United States AI NIAID NIH HHS; P30 AI117970 United States AI NIAID NIH HHS; P30 AI168436 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: CFIR; HIV/AIDS; implementation; qualitative; treatment initiation
تواريخ الأحداث: Date Created: 20230718 Date Completed: 20231031 Latest Revision: 20240409
رمز التحديث: 20240409
مُعرف محوري في PubMed: PMC11000141
DOI: 10.1177/09564624231185622
PMID: 37461333
قاعدة البيانات: MEDLINE
الوصف
تدمد:1758-1052
DOI:10.1177/09564624231185622